Insider Trading History of Burton Daniel D.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Burton Daniel D. since 2020. This trader's CIK number is 1780980. At the time of last reporting, Burton Daniel D. was the Chief Executive Officer of Health Catalyst, Inc.. (stock ticker symbol HCAT). Also see all insider trading activities at Health Catalyst, Inc..



Yearly summary of insider trading at Health Catalyst, Inc. (HCAT) by Burton Daniel D.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 HCAT 26,200 $204,517 0 $0 0 $0
2023 HCAT 49,050 $499,574 0 $0 0 $0
2022 HCAT 287,828 $2,995,152 0 $0 89,988 $971,870
2021 HCAT 0 $0 211,947 $10,567,783 172,946 $2,381,095
2020 HCAT 0 $0 928,306 $30,362,319 961,103 $9,150,090


Insider trading of Health Catalyst, Inc. (HCAT) by Burton Daniel D.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-02-27 HCAT Buy 26,200 7.81 204,517
2023-05-12 HCAT Buy 49,050 10.19 499,574
2022-11-11 HCAT Buy 197,078 10.14 1,998,173
2022-09-08 HCAT Buy 90,750 10.99 996,979
2022-05-18 HCAT Option Ex 89,988 10.80 971,870
2021-12-07 HCAT Sale 15,530 40.47 628,483
2021-12-07 HCAT Option Ex 15,530 10.80 167,724
2021-12-06 HCAT Option Ex 17,007 13.32 226,533
2021-12-03 HCAT Sale 36,212 41.29 1,495,265
2021-12-03 HCAT Option Ex 36,212 13.32 482,343
2021-12-06 HCAT Sale 21,972 40.06 880,242
2021-09-03 HCAT Sale 57,930 54.46 3,154,809
2021-09-03 HCAT Option Ex 57,930 13.32 771,627
2021-09-07 HCAT Sale 15,890 54.90 872,408
2021-09-07 HCAT Option Ex 10,819 15.84 171,372
2021-06-07 HCAT Option Ex 35,448 15.84 561,496
2021-06-07 HCAT Sale 62,984 55.07 3,468,528
2021-03-02 HCAT Sale 1,429 47.62 68,048
2020-12-01 HCAT Sale 4,482 34.98 156,793
2020-12-02 HCAT Sale 17,127 35.49 607,768
2020-09-30 HCAT Option Ex 54,406 12.31 669,901
2020-08-24 HCAT Option Ex 104,039 10.96 1,140,267
2020-08-25 HCAT Option Ex 17,013 15.84 269,485
2020-08-24 HCAT Sale 104,039 31.14 3,239,774
2020-08-25 HCAT Sale 17,013 30.61 520,767
2020-08-20 HCAT Option Ex 50,603 10.80 546,512
2020-08-21 HCAT Option Ex 72,265 10.80 780,462
2020-08-20 HCAT Sale 50,603 32.40 1,639,537
2020-08-21 HCAT Sale 72,265 32.38 2,339,940
2020-08-19 HCAT Sale 64,545 32.44 2,093,839
2020-08-18 HCAT Sale 85,142 32.58 2,773,926
2020-08-19 HCAT Option Ex 64,545 10.80 697,086
2020-08-18 HCAT Option Ex 85,142 10.80 919,533
2020-08-14 HCAT Sale 61,190 31.41 1,921,977
2020-08-14 HCAT Option Ex 61,190 10.30 630,257
2020-08-17 HCAT Sale 110,422 32.05 3,539,025
2020-08-17 HCAT Option Ex 110,422 9.11 1,006,275
2020-07-30 HCAT Sale 115,828 35.85 4,152,433
2020-07-31 HCAT Option Ex 84,742 10.30 872,842
2020-07-30 HCAT Option Ex 115,828 7.59 879,482
2020-07-31 HCAT Sale 84,742 35.24 2,986,308
2020-06-25 HCAT Option Ex 116,469 5.03 585,489
2020-06-26 HCAT Option Ex 24,439 6.24 152,499
2020-06-25 HCAT Sale 116,469 31.35 3,650,953
2020-06-26 HCAT Sale 24,439 30.25 739,279

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Burton Daniel D. (Chief Executive Officer of Health Catalyst, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.